ClinicalTrials.gov
public full text
Public Domain
Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
A long term study to demonstrate the safety of Tildrakizumab in Subjects with Psoriatic Arthritis who Have Previously Completed Study with Tildrakizumab
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Real-World Effectiveness and Safety of Tildrakizumab in a Large Spanish Multicenter Cohort from Spanish Psoriasis Group (GPS).#236089
- Efficacy and Safety of Tildrakizumab in the Treatment of Scalp Psoriasis#850619
- A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis#1161710
- A Study to Evaluate the Use of Glucocorticoids in Combination With Tocilizumab in Daily Clinical Practice#884691
- Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes#1058188
Record · ID 829305
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive